Question 1

Has Hanid Audish received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $13,624,789 in general payments to Hanid Audish across 1,969 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Hanid Audish did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Hanid Audish come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Eli Lilly	159	$7,283,217
Novo Nordisk AS	1,336	$912,256
Novartis	12	$767,054
Pfizer	83	$743,303
Sanofi US Services Inc.	39	$688,797
Merck	33	$682,691
Genentech, Inc.	42	$622,298
Johnson & Johnson	18	$517,262
Boehringer Ingelheim	30	$420,370
AbbVie	46	$300,123
Vivus LLC	2	$169,875
Hoffmann-la Roche Limited	9	$149,109
Acadia Pharmaceuticals Inc	14	$134,191
Amgen	2	$90,527
Regeneron	13	$70,068
F. Hoffmann-la Roche AG	7	$33,146
Boehringer Ingelheim International GmbH	123	$30,211
AstraZeneca	1	$10,293

Hanid Audish

Payments from drug & device makers

Who reported the general payments

How this compares

Other family medicine in Spring Valley